Bristol Myers Squibb faces a major patent cliff but is well-equipped with a robust pipeline and significant CAR-T optionality. BMY trades at a discounted 9.4x forward P/E, reflecting patent cliff ...

Nearly twenty years after I graduated high school and my last calculus class, I still get that nightmare where I’m at the exam for a calculus course I somehow forgot to attend, or that I faked my way ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. As a young child in Long Island, New York, I struggled to learn how to ...